BFC Planning’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$160K Sell
4,369
-1,670
-28% -$60.6K 0.01% 1023
2026
Q2
$214K Buy
6,039
+542
+10% +$16K 0.01% 909
2026
Q1
$152K Buy
5,497
+135
+3% +$3.47K 0.01% 965
2025
Q4
$116K Buy
+5,362
New +$106K 0.01% 1059

Other funds holding ROIV

BFC Planning's ROIV Position: Q3 2026 in Review

BFC Planning reduced its Roivant Sciences (ROIV) stake by 28% in Q3 2026, selling an estimated $60.6K and leaving 4,369 shares worth $160K. The position accounts for 0.01% of the portfolio, ranked #1023.

BFC Planning first reported a position in ROIV in Q4 2025 and has held it in 4 quarters since. The position peaked at $214K in Q2 2026. 402 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • BFC Planning held 4,369 shares of Roivant Sciences worth $160K as of Q3 2026.
  • BFC Planning sold 1,670 Roivant Sciences shares in Q3 2026, an estimated $60.6K.
  • Roivant Sciences made up 0.01% of BFC Planning's portfolio in Q3 2026, its #1023 holding.
  • BFC Planning first reported a position in Roivant Sciences in Q4 2025 and has held it in 4 quarters since.
  • BFC Planning's Roivant Sciences position peaked at $214K in Q2 2026.
  • 402 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.